Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Kiromic Biopharma Inc increased its cash reserves by 396.59%, or 2.56m. Cash Flow from Financing totalled 23.99m or -- of revenues. In addition the company used 21.23m for operations while cash used for investing totalled 206.60k.
Cash flow per share | -17.94 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -3.35 |
---|---|
Tangible book value per share | -3.35 |
More ▼
Balance sheet in USDView more
Current ratio | 0.3533 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | 1.74 |
More ▼